神州细胞：重组人凝血因子VIII（安佳因）的新增儿童适应症补充申请获得批准

array(1) { [480958]=> array(2) { [2]=> array(4) { [0]=> string(12) "并购重组" [1]=> string(18) "核准资产重组" [2]=> string(14) "神州细胞-U" [3]=> string(16) "凝血因子VIII" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }